HT
AMED

Headlands Technologies’s Amedisys AMED Stock Holding History

Headlands Technologies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,966
Closed -$1.37M – 627
2025
Q2 		$1.37M Buy
13,966
+2,925
+26% +$277K 0.16% 132
2025
Q1 		$1.02M Buy
11,041
+5,969
+118% +$550K 0.12% 189
2024
Q4 		$460K Buy
5,072
+2,619
+107% +$241K 0.05% 354
2024
Q3 		$237K Buy
+2,453
New +$239K 0.03% 484
2024
Q2 		– Sell
-57
Closed -$5.25K – 1127
2024
Q1 		$5.25K Sell
57
-43
-43% -$4.03K ﹤0.01% 1100
2023
Q4 		$9.51K Buy
100
+56
+127% +$5.23K ﹤0.01% 765
2023
Q3 		$4.11K Sell
44
-460
-91% -$42.5K ﹤0.01% 779
2023
Q2 		$46.1K Buy
+504
New +$41.3K 0.01% 483

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Headlands Technologies's AMED Position: Q3 2025 in Review

Headlands Technologies sold out of Amedisys (AMED) in Q3 2025, closing a stake of 13,966 shares — an estimated $1.37M sold.

Headlands Technologies first reported a position in AMED in Q2 2023 and held it in 8 quarters. The position peaked at $1.37M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Headlands Technologies reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Headlands Technologies sold 13,966 Amedisys shares in Q3 2025, an estimated $1.37M.
  • Headlands Technologies first reported a position in Amedisys in Q2 2023 and held it in 8 quarters.
  • Headlands Technologies's Amedisys position peaked at $1.37M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Headlands Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.